e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Duncan Keeley, Jane E. Scullion, Omar S. Usmani
Source:
Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020
Journal Issue:
February
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Duncan Keeley, Jane E. Scullion, Omar S. Usmani. Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers. Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Eosinophils and airway nerves in asthma
Related content which might interest you:
Minimising the environmental impact of inhaled therapies
Source: Eur Respir J, 55 (5) 2000721; 10.1183/13993003.00721-2020
Year: 2020
Modelling the beneficial impact of inhaled corticosteroids on health outcomes among COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004
Opinions on the environmental impact of inhaler devices in UK respiratory care
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
The use of pressurized metered-dose inhalers mith spacer in the treatment of asthmatic crises: impacts on treatment costs
Source: Eur Respir J 2006; 28: Suppl. 50, 710s
Year: 2006
Assessment of the technique in different inhalation devices and investigating the factors associated with inhaler misuse in COPD patients
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017
Pros: governments should impose targets for healthcare professionals to switch their respiratory disease patients to inhalers with a low global warming potential
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019
Personal strategies to minimise effects of air pollution on respiratory health: advice for providers, patients and the public
Source: Eur Respir J, 55 (6) 1902056; 10.1183/13993003.02056-2019
Year: 2020
Patients with underuse and overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhalation medication
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Cons - governments should impose targets for healthcare professionals to switch their respiratory disease patients to inhalers with a low global warming potential
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019
COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs
Source: Eur Respir J 2012; 40: 1072-1074
Year: 2012
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Feedback on inhaler use does not significantly improve inhaled corticosteroid adherence or clinical outcomes
Source: Virtual Congress 2020 – Digital technologies in airway diseases
Year: 2020
Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice
Source: Annual Congress 2010 - Management of airway disease
Year: 2010
What are the key issues in the inhaler therapy in children?
Source: Annual Congress 2004 - How can we improve asthma management?
Year: 2004
Optimal adherence with inhaled corticosteroids is related to better health status
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept